Treeline Biosciences
About
What does Treeline Biosciences do?
Treeline Biosciences is a biotechnology company focused on discovering and developing new medicines for diseases with high unmet medical needs. They leverage a deep understanding of biological pathways and cutting-edge research to create innovative therapeutic candidates.
What is Treeline Biosciences's revenue?
StartupHub estimates Treeline Biosciences's annual revenue at $48.7M (range $10.3M to $198.4M, 29% confidence), based on comparable companies in the sector.
What is Treeline Biosciences's valuation?
StartupHub estimates Treeline Biosciences's effective valuation at $756.5M (range $500.0M to $1.2B, 19% confidence), based on comparable companies in the sector.
How much funding has Treeline Biosciences raised?
Treeline Biosciences has raised a total of $200M in funding. The most recent round on record is Series B.
Where is Treeline Biosciences headquartered?
Treeline Biosciences is headquartered in Cambridge, United States.
When was Treeline Biosciences founded?
Treeline Biosciences was founded in 2019.
What industry does Treeline Biosciences operate in?
Treeline Biosciences operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Therapeutics.
What is Treeline Biosciences's current status?
Treeline Biosciences's current operating status is: Inactive.
No comments yet. Be the first to share your take.